Matching slides 18,554
Current window 2,731-2,760
Pages 619
Rows per page 30
Component: Quoteclear collectionreset all

Component

2,731-2,760 of 18,554

filter-aware
29
The slide uses a direct quote from a 20-F filing to contrast with a contractual requirement, alleging management dishonesty.iQIYI, Inc. (IQ) · Wolfpack Research
Research note Short seller Beat · The Victory3 hits
05
The slide uses patient anecdotes and FDA data to argue against the viability and safety of the Inspire system.Inspire Medical Systems, Inc. (INSP) · Wolfpack Research
Research note Short seller Beat · The MonsterLoop · Pattern Hunter3 hits
08
The slide uses a table to highlight missed performance targets and quotes from executives to contrast with actual financial outcomes.GTT Communications, Inc. (GTT) · Wolfpack Research
Research note Short seller Beat · The MonsterLoop · Pattern Hunter3 hits
09
The slide uses expert testimony and competitor insight to build a bearish thesis on GTT's operational health.GTT Communications, Inc. (GTT) · Wolfpack Research
Research note Short seller Beat · The MonsterLoop · Pattern Hunter3 hits
05
Includes two quotes from industry figures to support the argument that recoverability testing is standard and inexpensive.Ramaco Resources, Inc. (METC) · Wolfpack Research
Research note Short seller Beat · Villain CritiqueLoop · Zoom In3 hits
06
Uses quotes from Randall Atkins (METC CEO) and Rick Pobjoy (AR3 Founder) to frame the contradiction.Ramaco Resources, Inc. (METC) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction3 hits
03
The slide uses anecdotal evidence from former employees and financial data to challenge the company's narrative.Innodata, Inc. (INOD) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction3 hits
07
Uses a dialogue-based format to contrast management's public statements with internal reality.Innodata, Inc. (INOD) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction3 hits
17
This is a research note page from Wolfpack Research, focusing on corporate governance and disclosure failures.Qutoutiao, Inc. (QTT) · Wolfpack Research
Research note Short seller 3 hits
11
Includes expert testimony snippets and statutory filing data.Mercury General Corporation (MCY) · Wolfpack Research
Research note Short seller Beat · Solution (Provide relief)Loop · Analogy3 hits
92
The slide uses a Q&A format with an 'IDT ex-regional sales manager' to build a narrative of a 'fatal flaw'.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction3 hits
94
Uses expert testimony to undermine the company's operational efficiency claims.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction3 hits
96
The slide uses a quote from an industry executive to validate the thesis of operational failure.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction3 hits
98
The slide uses a Q&A format to present expert testimony as a critique of the target company's core technology.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction3 hits
102
Uses Q&A format to present expert testimony as evidence of operational failure.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 3 hits
103
Uses Q&A format to frame expert testimony as a critique of the company's core technology.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 3 hits
104
The slide uses a Q&A format to highlight expert skepticism regarding Twist's unit economics.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 3 hits
106
The slide uses a 'villain critique' approach by citing external experts to undermine the company's technological claims.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 3 hits
119
The slide uses excerpts from an S-1/A filing to support the claim of misclassification.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 3 hits
159
Uses direct quotes to undermine the company's technical capabilities.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 3 hits
163
The slide uses direct quotes from a major genomics center and an ex-IDT manager to build a case against Twist's product reliability.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 3 hits
164
The slide uses direct quotes from a customer to undermine the company's quality reputation.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 3 hits
166
The slide uses direct quotes from an IDT ex-regional sales manager to undermine the target company's marketing claims.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 3 hits
169
The slide uses direct quotes from a competitor to undermine the target company's credibility.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 3 hits
180
The slide uses a Q&A format to validate the thesis that Twist is a 'race to the bottom' competitor.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 3 hits
182
The slide uses direct quotes from a former competitor employee to frame Twist's strategy as low-quality/low-cost vs. the industry standard of quality-focused value propositions.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 3 hits
190
The slide uses a Q&A format to present primary research findings from Scorpion Capital.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 3 hits
193
The slide uses highlighted text to emphasize key negative sentiment regarding Twist's market position.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 3 hits
195
Uses expert testimony to frame the company as a commodity player in a niche market.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 3 hits
204
The slide uses highlighted text to emphasize key competitive advantages (speed, delivery times).Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 3 hits